Medicare and Medicare Advantage (MA), the federal health insurance programs for seniors and certain younger people with disabilities, have always operated under a principle of necessity, covering services deemed medically necessary for diagnosis or treatment.
However, a growing concern among women, particularly those with dense breast tissue, is casting a spotlight on what many see as a significant oversight in these programs. Dense breast tissue, common among a substantial portion of the female population, can make mammograms less effective for detecting breast cancer. As a result, many healthcare providers recommend supplementary ultrasound screenings for better accuracy. Yet, reports are surfacing that Medicare is not covering these ultrasounds, leaving many women facing unexpected bills, and raising questions about the adequacy of Medicare’s coverage policies.
High breast density is not just a common condition; it’s a critical factor in breast cancer screening. Dense breast tissue appears white on mammograms, the same color as potential tumors, making it challenging to spot abnormalities. This limitation of mammograms is well-documented, and supplementary screenings like ultrasounds or MRIs, which can navigate dense tissue more effectively, are often advised by doctors. The rationale is clear: ensuring that all women, regardless of breast density, have access to reliable cancer screening methods.
However, the issue at hand is that Medicare, and by extension MA plans, often only cover the cost of traditional mammograms under the preventive services benefit, leaving the deductible and potentially more for ultrasounds to be paid out-of-pocket by the patient. This practice has left many women surprised and burdened by unexpected medical bills, which is especially troubling for those on fixed incomes.
The refusal of Medicare to cover these essential supplementary screenings raises significant concerns about the program’s overarching approach to preventive care. Early detection of breast cancer can be lifesaving, and for women with dense breast tissue, ultrasounds are a critical part of this early detection strategy. By not covering them, Medicare may inadvertently be placing women at higher risk by potentially delaying or deterring essential diagnostic services.
This issue also highlights a broader debate about what constitutes “medically necessary” care and how insurance coverage decisions are made. Critics argue that the current policy overlooks the nuanced needs of women with dense breast tissue and fails to keep pace with advancements in medical understanding and technology. The situation calls for a reevaluation of Medicare’s coverage policies to ensure that they align with contemporary medical practice and the specific needs of the populations they serve.
The financial implications for patients are significant. Out-of-pocket costs for healthcare can be a substantial burden, particularly for the elderly and those on fixed incomes, which make up a large portion of Medicare beneficiaries. The additional cost of ultrasounds, deemed necessary by a healthcare provider but not covered by Medicare, can deter women from following through with recommended screenings, potentially compromising their health.
Advocates for women’s health are calling for policy changes to address this gap in coverage. They argue that Medicare should adapt its coverage decisions based on current medical guidelines and the individual needs of patients, rather than applying a one-size-fits-all approach. The goal is to ensure that all women, including those with dense breast tissue, have access to the screenings necessary for effective breast cancer detection without the barrier of prohibitive costs.
In conclusion, the issue of Medicare not covering ultrasound screenings for women with dense breast tissue is more than a matter of insurance policy; it’s a public health concern that highlights the need for a more adaptive and inclusive approach to healthcare coverage. As this debate unfolds, it will be critical for policymakers, healthcare providers, and insurance programs to work together to find solutions that prioritize the health and well-being of all patients, ensuring equitable access to lifesaving screenings and treatments.
As the Centers for Medicare & Medicaid Services (CMS) clarifies existing Medicare policies like the Two-Midnight Rule, which guides the appropriateness of inpatient services, some
Today we’re talking about a major shift in Medicare rules that’s going to impact hospitals, surgeons, and physician advisors alike: the phasing out of the
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
